Kabra Drugs informs about standalone financial results

15 Feb 2017

Kabra Drugs has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

3.77 0.00 (0.00%) Jun 01, 18:01
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 495.00
Lupin 907.70
Dr. Reddys Lab 3999.50
Piramal Enterprises 1081.55
Cadila Healthcare 362.75
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719